Endometriosis therapy with gestrinone by oral, vaginal or parenteral administration

E Coutinho, Emília Coutinho, Coutinho E, Maria Tereza Gonçalves, Gonçalves MT, M T Gonçalves, G. Azadian‐Boulanger, Azadian-Boulanger G, G Azadian-Boulanger, Silva AR, A. R. Silva
Contributions to gynecology and obstetrics · 1987 · vol. 16 , pp. 227–235 · doi:10.1159/000414891 · PMID:3691096 · W2417873873
Other OA: closed CC0 ⤵ 3 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This paper investigated the efficacy and tolerability of gestrinone therapy for endometriosis administered orally, vaginally, or parenterally.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Genital Neoplasms, Female Gestrinone Norpregnatrienes Administration, Intravaginal Administration, Intravaginal Administration, Oral Administration, Oral Adult Adult Drug Implants Drug Implants Endometriosis Endometriosis Female Female Genital Neoplasms, Female Genital Neoplasms, Female Gestrinone Gestrinone

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (5)

Source provenance

europepmc
last seen: 2026-10-19T06:17:24.038039+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:39:06.473101+00:00
unpaywall
last seen: 2026-10-19T06:34:38.229974+00:00
License: CC0 · commercial use OK